Home/Publication/SPRIM Tackles Peanut Allergy via Prota Therapeutics
SPRIM Tackles Peanut Allergy via Prota Therapeutics 

18 Jan 2024

US$ 19.00

Singapore-based SPRIM Global Investments (SGI) has led the US$21 million equity and debt financing of Prota...

Price / article: US$19.00
OR existing subscriber
Related Publications

Francisco Partners has raised US$21 bn for its latest buyout funds, which consists of flagship fund ......

Just over two years after it raised US$3.4 bn of private credit financing from investors including Ares Management Corp...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.